Special Commission on the Public Health Effects of Xylazine Final Report

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 1 Sponsors

Mar 30, 2026 · Senate

Placed on file

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Introduced — base rate 3%, measured from MA's completed sessions
Momentum -8 14/100 from the pace of recorded action
Time since last action -22 198 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.